0001493152-25-007952.txt : 20250224 0001493152-25-007952.hdr.sgml : 20250224 20250224060312 ACCESSION NUMBER: 0001493152-25-007952 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250224 DATE AS OF CHANGE: 20250224 EFFECTIVENESS DATE: 20250224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncocyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-539015 FILM NUMBER: 25654032 BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20200213 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 D 1 primary_doc.xml X0708 D LIVE 0001642380 Oncocyte Corp 15 CUSHING IRVINE CA CALIFORNIA 92618 (949) 409-7600 CALIFORNIA None OncoCyte Corp Oncocyte Corp Corporation true Joshua Riggs 15 Cushing Irvine CA CALIFORNIA 92618 Executive Officer Director President and Chief Executive Officer and Director James Liu 15 Cushing Irvine CA CALIFORNIA 92618 Executive Officer Senior Director, Controller & Principal Accounting Officer Louis Silverman 15 Cushing Irvine CA CALIFORNIA 92618 Director Andrew Arno 15 Cushing Irvine CA CALIFORNIA 92618 Director Andrew Last 15 Cushing Irvine CA CALIFORNIA 92618 Director Andrea James 15 Cushing Irvine CA CALIFORNIA 92618 Executive Officer Chief Financial Officer Biotechnology Decline to Disclose 06b false 2025-02-10 false true true true false 0 21743597 21743597 0 false 12 0 0 The Company did not engage a placement agent. 0 false Oncocyte Corp /s/ Joshua Riggs Joshua Riggs President and Chief Executive Officer and Director 2025-02-24